These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 6360225

  • 1. The role of placental urokinase inhibitor in toxemia of pregnancy.
    Terao T, Kobayashi T.
    Biol Res Pregnancy Perinatol; 1983; 4(4):145-51. PubMed ID: 6360225
    [Abstract] [Full Text] [Related]

  • 2. Purification and characterization of placental plasminogen activator (PPA).
    Kobayashi T, Terao T.
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 May; 37(5):783-92. PubMed ID: 3923141
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Kinetics of the reaction between urokinase and an inhibitor of fibrinolysis from placental tissue.
    Christensen U, Holmberg L, Bladh B, Astedt B.
    Thromb Haemost; 1982 Aug 24; 48(1):24-6. PubMed ID: 6813991
    [Abstract] [Full Text] [Related]

  • 7. Expression and localization of the urokinase-type plasminogen activator receptor (uPAR) in the human placenta.
    Nishida Y, Hayashi Y, Imai Y, Itoh H.
    Kobe J Med Sci; 1998 Feb 24; 44(1):31-43. PubMed ID: 9846056
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Fibrinolytic therapy for toxemia of late pregnancy--experimental studies of pregnant rabbits treated with urokinase].
    Kano A.
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Jan 24; 36(1):72-80. PubMed ID: 6699451
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Expression of urokinase, plasminogen activator inhibitors and urokinase receptor in pregnant rhesus monkey uterus during early placentation.
    Feng Q, Liu Y, Liu K, Byrne S, Liu G, Wang X, Li Z, Ockleford CD.
    Placenta; 2000 Jan 24; 21(2-3):184-93. PubMed ID: 10736241
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Development of Immunoassay of Urinary urokinase inhibitor using biological binding activity of urokinase and urokinase inhibitor (author's transl)].
    Yoshio T, Kan S, Ninagawa T.
    Nihon Sanka Fujinka Gakkai Zasshi; 1982 Apr 24; 34(4):451-9. PubMed ID: 7040569
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Isolation of peptides with anti-urokinase activity from the human placenta.
    Uszynski M.
    Thromb Haemost; 1980 Feb 29; 42(5):1411-6. PubMed ID: 6768150
    [Abstract] [Full Text] [Related]

  • 18. Fibrinolytic parameters in normotensive pregnancy with intrauterine fetal growth retardation and in severe preeclampsia.
    Estellés A, Gilabert J, España F, Aznar J, Galbis M.
    Am J Obstet Gynecol; 1991 Jul 29; 165(1):138-42. PubMed ID: 1906680
    [Abstract] [Full Text] [Related]

  • 19. Coagulation, fibrinolysis, platelet and kinin-forming systems during toxemia of pregnancy.
    Maki M.
    Biol Res Pregnancy Perinatol; 1983 Jul 29; 4(4):152-4. PubMed ID: 6652168
    [Abstract] [Full Text] [Related]

  • 20. [New theory of fibrinolytic mechanism in the development of hyaline membrane disease in newborn infants].
    Uszyńska-Folejewska R, Uszyński M.
    Pediatr Pol; 1975 Dec 29; 50(12):1513-5. PubMed ID: 127976
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.